ENOV
Enovis Corporation
ENOV's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over ENOV overall, supported by stronger valuation and stronger modeled upside.
ENOV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Healthy |
ENOV's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
ENOV PE Valuation
ENOV has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
ENOV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ENOV, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
ENOV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.56 | — |
| Q3 2026 | -$9.25 | +$15.05 |
| Q2 2026 | -$19.30 | -$4.41 |
| Q1 2026 | -$19.92 | -$5.33 |
| Q4 2025 | -$20.75 | -$5.82 |
| Q3 2025 | -$24.30 | -$22.11 |
| Q2 2025 | -$14.89 | -$13.23 |
| Q1 2025 | -$14.59 | -$13.09 |
| Q4 2024 | -$14.93 | -$14.32 |
ENOV is still losing money, but far less than before: $9.25 per share over the past year, against $24.30 at its worst in late 2025.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over ENOV on earnings quality, reporting a profit while its opponent remains loss making.
ENOV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $558.7M | +1.8% |
| Q2 2026 | $582.8M | +3.2% |
| Q1 2026 | $589.2M | +5.4% |
| Q4 2025 | $575.8M | +2.6% |
| Q3 2025 | $548.9M | +8.6% |
| Q2 2025 | $564.5M | +7.5% |
| Q1 2025 | $558.8M | +8.2% |
| Q4 2024 | $561M | +23% |
ENOV's revenue has grown year over year for 14 quarters in a row: $559M last quarter, up 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.6% | +102 points |
| Q2 2026 | 3% | +6 points |
| Q1 2026 | 1.1% | +9.5 points |
| Q4 2025 | -87% | +31 points |
| Q3 2025 | -102% | -96 points |
| Q2 2025 | -3% | +5.4 points |
| Q1 2025 | -8.4% | -1.6 points |
| Q4 2024 | -119% | -117 points |
ENOV's operating margin was 0.6% last quarter, up 102 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over ENOV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over ENOV on profitability, with a higher operating margin.
ENOV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $35M | +20% |
| Q2 2026 | $31.1M | +816% |
| Q1 2026 | -$28.9M | +$16M |
| Q4 2025 | $32.3M | -8.1% |
| Q3 2025 | $29.1M | +1128% |
| Q2 2025 | $3.4M | +$35M |
| Q1 2025 | -$44.9M | +$28.2M |
| Q4 2024 | $35.1M | -13% |
ENOV still generates free cash flow, though less than at its 2020 peak: $70M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over ENOV on cash flow, with more consistent year-over-year improvement.
ENOV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +892K shares |
| 1 year | +2.3% | +1.3M shares |
| 3 years | +7.2% | +3.9M shares |
| 5 years | +8.9% | +4.8M shares |
| Available history | +28% | +12.9M shares |
ENOV has 58M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over ENOV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
ENOV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 5.7x | High |
| Q2 2025 | 7.9x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 8.4x | High |
| Q3 2024 | 8.7x | High |
ENOV's net debt is about 1.4 years of its operating earnings (EBITDA), down from 7.9 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over ENOV on leverage, with a lower net debt burden relative to earnings.
ENOV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.6 | Neutral |
| Stochastic | 58.1 | Neutral |
ENOV's weekly RSI is 61 (neutral) and its Stochastic is 58 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
ENOV PE vs Industrials Sector
| Metric | ENOV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ENOV has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
ENOV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 31% above |
| 20 week MA | $23.0 | 20% above |
| 50 week MA | $23.7 | 17% above |
| 100 week MA | $29.2 | 5.2% below |
| 200 week MA | $41.1 | 33% below |
ENOV has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
ENOV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $63.3 | +1.4% |
| 2021 | $63.3 | $77.7 | +23% |
| 2022 | $77.7 | $52.9 | -32% |
| 2023 | $52.9 | $56.0 | +6% |
| 2024 | $56.0 | $44.3 | -21% |
| 2025 | $44.3 | $27.4 | -38% |
| 2026 YTD | $27.4 | $27.6 | +0.9% |
ENOV has finished lower in three of the last six years. It's up 0.9% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over ENOV on returns for 2026, with the stronger performance.